Growth Catalysts | Delve into SLP's M&A strategy and potential for margin improvement, which could drive long-term value creation and strengthen its market position |
Financial Outlook | Analysts project a return to profitability despite lowered guidance, with revenue expectations of $76-80 million and adjusted EPS of $0.93-$1.06 for fiscal year 2025 |
Strategic Resilience | Explore SLP's strong competitive position and essential software solutions, which provide a buffer against market volatility and potential for future growth |
Market Headwinds | Simulations Plus faces challenges in the biopharma sector, with declining organic revenue growth and cautious client spending impacting its financial performance |

Metrics to compare | SLP | Peers Peers - average of corresponding metrics from companies closely matching SLP: | Sector Sector - Average of metrics from a broad group of related sector companies | Relationship RelationshipSLPPeersSector |
|---|---|---|---|---|
P/E Ratio | 46.2x | 0.0x | −0.2x | |
PEG Ratio | 0.41 | 0.00 | 0.00 | |
Price / Book | 2.7x | 0.0x | 2.6x | |
Price / LTM Sales | 4.6x | 0.0x | 2.8x | |
Upside (Analyst Target) | - | 0.0% | 65.0% | |
Fair Value Upside | Unlock | 0.0% | 9.6% | Unlock |